Comparison of the nine polymorphic membrane proteins of Chlamydia trachomatis for their ability to induce protective immune responses in mice against a C …

S Pal, A Favaroni, DF Tifrea, PT Hanisch, SET Luczak… - Vaccine, 2017 - Elsevier
Objectives To test vaccines, formulated with novel antigens, to protect mice against
Chlamydia infections. Methods To determine the ability of polymorphic membrane proteins …

Vaccination with the Chlamydia trachomatis Major Outer Membrane Protein Can Elicit an Immune Response as Protective as That Resulting from Inoculation with …

S Pal, EM Peterson, LM de la Maza - Infection and immunity, 2005 - Am Soc Microbiol
ABSTRACT BALB/c mice were vaccinated by the intramuscular (im) and subcutaneous (sc)
routes with a native preparation of the Chlamydia trachomatis mouse pneumonitis (MoPn) …

Comparison of Chlamydia outer membrane complex to recombinant outer membrane proteins as vaccine

H Yu, KP Karunakaran, X Jiang, Q Chan, C Rose… - Vaccine, 2020 - Elsevier
The Chlamydial outer membrane complex (COMC) from the elementary body (EB) is a
protein rich insoluble outer membrane shell from which cytosolic proteins have been …

Immunization with the Chlamydia trachomatis major outer membrane protein, using adjuvants developed for human vaccines, can induce partial protection in a mouse …

S Pal, EM Peterson, R Rappuoli, G Ratti… - Vaccine, 2006 - Elsevier
To test several vaccines for Chlamydia trachomatis we vaccinated BALB/c and C3H/HeN
female mice with a purified preparation of the native mouse pneumonitis (MoPn) major outer …

Evaluation of a multisubunit recombinant polymorphic membrane protein and major outer membrane protein T cell vaccine against Chlamydia muridarum genital …

H Yu, KP Karunakaran, X Jiang, RC Brunham - Vaccine, 2014 - Elsevier
An efficacious vaccine is needed to control Chlamydia trachomatis infection. In the murine
model of Chlamydia muridarum genital infection, multifunctional mucosal CD4 T cells are …

Protection against genital tract Chlamydia trachomatis infection following intranasal immunization with a novel recombinant MOMP VS2/4 antigen

R Hadad, E Marks, I Kalbina, K Schön, M Unemo… - APMIS, 2016 - Wiley Online Library
The asymptomatic nature of most Chlamydia trachomatis infections and the lack of
appropriate effects by current prevention and management call for vaccine development. We …

Enhancement of the protective efficacy of a Chlamydia trachomatis recombinant vaccine by combining systemic and mucosal routes for immunization

P Ralli-Jain, D Tifrea, C Cheng, S Pal, LM De la Maza - Vaccine, 2010 - Elsevier
Chlamydia trachomatis causes respiratory and sexually transmitted infections. Here, we
tested a vaccine formulated with the recombinant major outer membrane protein from C …

Protection against an intranasal challenge by vaccines formulated with native and recombinant preparations of the Chlamydia trachomatis major outer membrane …

G Sun, S Pal, J Weiland, EM Peterson, LM de la Maza - Vaccine, 2009 - Elsevier
To compare the ability of a native and a recombinant preparation of the major outer
membrane protein of Chlamydia trachomatis mouse pneumonitis (MoPn; Ct-nMOMP and Ct …

Immunogenicity of a vaccine formulated with the Chlamydia trachomatis serovar F, native major outer membrane protein in a nonhuman primate model

C Cheng, S Pal, I Bettahi, KL Oxford, PA Barry… - Vaccine, 2011 - Elsevier
To determine the ability of a vaccine formulated with the genital Chlamydia trachomatis,
serovar F, native major outer membrane protein (Ct-F-nMOMP), to induce systemic and …

[HTML][HTML] Analysis of Polymorphic Membrane Protein Expression in Cultured Cells Identifies PmpA and PmpH of Chlamydia psittaci as Candidate Factors in …

S Van Lent, WH De Vos, H Huot Creasy, PX Marques… - PLoS …, 2016 - journals.plos.org
The polymorphic membrane protein (Pmp) paralogous families of Chlamydia trachomatis,
Chlamydia pneumoniae and Chlamydia abortus are putative targets for Chlamydia vaccine …